Key result
RVP in patients with myocardial fibrosis is linked to a steeper ~12% LVEF decline.
Why the study?
Long-term RV pacing leads to heart failure or LV dysfunction in up to a fifth of patients, but whether focal fibrosis on late gadolinium enhancement CMR predicts LV deterioration after RV pacing was unknown.
Does right ventricular pacing worsen left ventricular function in patients with myocardial fibrosis compared to those without?
Observational (n=84)
Does right ventricular pacing worsen left ventricular function in patients with myocardial fibrosis compared to those without?
Answers are grounded in this paper and cite their sources.
Myocardial fibrosis detected on CMR identifies patients at high risk of immediate and medium-term deterioration in LV function following right ventricular pacing.
Background: Long-term right ventricular (RV) pacing leads to heart failure or a decline in left ventricular (LV) function in up to a fifth of patients. We aimed to establish whether patients with focal fibrosis detected on late gadolinium enhancement cardiovascular magnetic resonance (CMR) have deterioration in LV function after RV pacing. Methods: We recruited 84 patients with LV ejection fraction ≥40% into 2 observational CMR studies. Patients (n=34) with a dual-chamber device and preserved atrioventricular conduction underwent CMR in 2 asynchronous pacing modes (atrial asynchronous and dual-chamber asynchronous) to compare intrinsic atrioventricular conduction with forced RV pacing. Patients (n=50) with high-grade atrioventricular block underwent CMR before and 6 months after pacemaker implantation to investigate the medium-term effects of RV pacing. Results: The key findings were (1) initiation of RV pacing in patients with fibrosis, compared with those without, was associated with greater immediate changes in both LV end-systolic volume index (5.3±3.5 versus 2.1±2.4 mL/m 2 ; P <0.01) and LV ejection fraction (−5.7±3.4% versus −3.2±2.6%; P =0.02); (2) medium-term RV pacing in patients with fibrosis, compared with those without, was associated with greater changes in LV end-systolic volume index (8.0±10.4 versus −0.6±7.3 mL/m 2 ; P =0.008) and LV ejection fraction (−12.3±7.9% versus −6.7±6.2%; P =0.012); (3) patients with fibrosis did not experience an improvement in quality of life, biomarkers, or functional class after pacemaker implantation; (4) after 6 months of RV pacing, 10 of 50 (20%) patients developed LV ejection fraction <35% and were eligible for upgrade to cardiac resynchronization according to current guidelines. All 10 patients had fibrosis on their preimplant baseline scan and were identified by >1.1 g of fibrosis with 90% sensitivity and 70% specificity. Conclusions: Fibrosis detected on CMR is associated with immediate- and medium-term deterioration in LV function following RV pacing and could be used to identify those at risk of heart failure before pacemaker implantation.
No takes yet. Share an insight, caveat, or question.
Saunderson et al. (2021) conducted an observational in Myocardial Fibrosis (n=84). Right ventricular pacing vs. Patients without myocardial fibrosis was evaluated on Changes in LV end-systolic volume index and LV ejection fraction. Right ventricular pacing in patients with myocardial fibrosis, compared to those without, was associated with greater medium-term decline in LV ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: